Catalyst Pharmaceutical
CPRX
CPRX
271 hedge funds and large institutions have $1.5B invested in Catalyst Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 91 increasing their positions, 90 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
271
Holders Change
+3
Holders Change %
+1.12%
% of All Funds
3.94%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
36
Increased
91
Reduced
90
Closed
30
Calls
$522K
Puts
$789K
Net Calls
-$267K
Net Calls Change
+$82K
Top Buyers
| 1 |
1
Pacer Advisors
Malvern,
Pennsylvania
|
$46M |
| 2 |
2
First Trust Advisors
Wheaton,
Illinois
|
$38.3M |
| 3 |
3
BlackRock
New York
|
$290M |
| 4 |
4
Renaissance Technologies
New York
|
$33.7M |
| 5 |
IHAM
5
Integral Health Asset Management
New York
|
$4.26M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$93.5M |
| 2 |
2
Morgan Stanley
New York
|
$15.7M |
| 3 |
3
Janus Henderson Group
London,
United Kingdom
|
$33.7M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$9.03M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$18.9M |
